Clinician-Supervised Heavy Metal Detox Program

Measurable reduction of toxic metal burden through evidence-based protocols and objective lab tracking

About Heavy Metal Detox Treatment

Through clinical experience supported by a 50-patient IRB study and published case research, Leading Edge Clinic offers a clinician-supervised heavy metal detoxification program that goes far beyond consumer supplement protocols. Our approach combines proprietary weight-based oral dosing of a unique ionic mineral solution, serial laboratory monitoring, and comprehensive wellness guidance to achieve measurable reductions in 20 different heavy metals, including mercury, lead, gadolinium, arsenic, and cadmium—proven by objective lab data before, during, and after treatment.

If you’re concerned about heavy metal exposure from food, water, environmental sources, or occupational contact, you’re not alone. Unlike IV chelation programs that indiscriminately target both beneficial and toxic minerals, our protocol works through redox buffering and mineral-competitive displacement to support the body’s natural detoxification pathways.

Our treatment approach addresses:

  • Measurable reduction of mercury, lead, arsenic, and cadmium through serial urine toxic metals panels
  • Mobilization and excretion monitoring across a 3-4 month treatment arc
  • Clinical management of the counterintuitive mobilization phase (labs rise before they fall)
  • Broader wellness applications including therapeutic bathing, wound care, and skin support

On this page, you will find more information about our care model and costs, our treatment approach, answers to frequently asked questions, and additional clinical resources.

Provider Appointments

Heavy metal detoxification requires careful clinical oversight and patient education to navigate the mobilization arc—the period when lab values initially rise as metals move from tissue storage into circulation before being excreted. Our program includes three structured visits over 3-4 months, designed to set expectations, validate the mechanism, and assess trajectory toward resolution.

Visit 1 (60 minutes): Comprehensive history, screening, informed consent, baseline urine toxic metals panel ordered, weight-based oral dosing protocol established, topical use guidance provided, and critical education on the mobilization arc.

Visit 2 (~6-8 weeks): First retest results reviewed. Labs expected to be elevated, demonstrating active mobilization. Clinical context provided, dosing adjusted if indicated.

Visit 3 (~3-4 months): Second retest results reviewed. Trajectory assessment and natural continuation conversation. Some patients. may require ongoing à la carte monitoring beyond this point given the extended treatment arc.

See a list of our providers

Evidence-Based Treatment

Our heavy metal detoxification protocol is informed by a 50-patient IRB study and published case research documenting measurable reductions in 20 heavy metals, alongside clinical improvement. The treatment arc—baseline → mobilization peak → downslope—has been observed consistently across clinical cohorts, providing the foundation for patient education and expectation-setting.

Clinical evidence includes:

  • Published case study: “From Fatigue to Fertility” documenting ~9% reduction in blood methylmercury (the dominant neurotoxic form), +115% increase in urinary inorganic mercury (consistent with active hepatic demethylation and renal excretion), and 30-35% reduction in blood lead over the treatment period
  • 2026 update: Viable pregnancy maintained through second trimester with continued protocol adherence (oral dosing + daily therapeutic bathing)
  • Proprietary weight-based dosing developed through clinical observation and IRB data
  • Serial lab monitoring demonstrating predictable mobilization and downslope patterns

 

This program represents a fundamentally different value proposition from consumer detox products: clinician supervision, objective lab tracking, and evidence-backed protocols unavailable in the supplement market.

Pricing

The program cost is $2,500, and is all inclusive of the following:

  • Initial consultation (60 min)
  • Two follow-up visits (30 min each)
  • Two bottles of proprietary ionic mineral solution
  • Three Doctor’s Data Urine Toxic Metals & Essential Elements  tests

 

Patients can purchase 30 minute la carte appointments at $450 for continued care after their initial 3 visits and tests. Patients may require extended care given the 6+ month treatment arc observed in the IRB data for some study participants.

Become A Patient - No Matter Where You Are Located

Receive clinician-supervised heavy metal detoxification in all 50 states. To become a patient of Leading Edge Clinic, you must first register. Registration does not require a monetary commitment, and allows us to reach out to interested patients who may have questions about our care model, treatment modalities, etc…

Operating under the legal framework of the First Nations Medical Board allows us to see patients in all 50 states. More information about the First Nations Medical Board can be found under the “General Practice” section of our FAQ page

Frequently Asked Questions

How do I know if I need heavy metal detox?

Quick Answer: You may benefit from heavy metal detoxification if you have documented exposure, unexplained chronic symptoms, trace mineral deficiencies coupled with toxic metal accumulation, or elevated levels on laboratory testing.


Common Sources of Heavy Metal Exposure:

The Doctor’s Data Urine Toxic Metals panel tests for 20 toxic elements. Below are the most common sources for metals we see clinically:

Mercury (Hg):

  • Fish consumption (especially large predatory fish like tuna, swordfish, shark)
  • Dental amalgam fillings
  • Occupational exposure (dentistry, manufacturing)
  • Environmental contamination

 

Lead (Pb):

  • Old paint in homes built before 1978
  • Contaminated water (lead pipes, plumbing)
  • Occupational exposure (construction, battery manufacturing)
  • Imported ceramics and pottery
  • Certain cosmetics and traditional medicines

 

Arsenic (As):

  • Contaminated well water
  • Rice and rice products
  • Seafood (organic arsenic, generally less toxic)
  • Occupational exposure (pesticides, wood treatment)

 

Cadmium (Cd):

  • Smoking and secondhand smoke
  • Industrial exposure (battery manufacturing, metal plating)
  • Contaminated soil → vegetables and grains
  • Shellfish

 

Aluminum (Al):

  • Cookware and food containers
  • Antacids and buffered aspirin
  • Antiperspirants
  • Processed foods (additives, baking powder)
  • Contaminated drinking water

 

Additional toxic metals tested:

  • Antimony: Flame retardants (on clothes, electronics, furniture), ceramics, batteries
  • Barium: Industrial exposure, contaminated drinking water
  • Beryllium: Aerospace and electronics manufacturing
  • Bismuth: Medications (Pepto-Bismol), cosmetics
  • Cesium: Nuclear fallout, certain medical procedures
  • Gadolinium: MRI contrast agents
  • Nickel: Stainless steel, jewelry, occupational exposure
  • Palladium: Dental work, catalytic converters
  • Platinum: Chemotherapy agents, catalytic converters
  • Tellurium: Electronics manufacturing
  • Thallium: Rat poison, industrial contamination, soil
  • Thorium: Rare earth element exposure
  • Tin: Canned foods, solder
  • Tungsten: Industrial exposure, military applications
  • Uranium: Contaminated well water, phosphate fertilizers

The Critical Connection: Trace Mineral Deficiency and Heavy Metal Toxicity

Research has established that toxic metals and essential minerals compete for the same binding sites, transporters, and metabolic pathways in the body. This creates a dangerous double burden.

The science of mineral displacement and mimicry:

Heavy metals use the same intestinal transporters as essential minerals. When trace mineral status is low, toxic metals are more easily absorbed because they “win” the competition for binding sites. Studies show that iron and calcium deficiency increases intestinal absorption and body retention of lead, zinc deficiency increases cadmium absorption, and selenium deficiency increases mercury toxicity. Trace Mineral Imbalances in Global Health: Challenges, Biomarkers, and the Role of Serum Analysis – PMC +2

Examples of documented mineral displacement:

  • Excessive zinc intake can lead to copper deficiency through competitive inhibition at absorption sites and displacement from biological binding sites PubMed Central
  • Cadmium competes with copper and zinc for binding with metallothionein (MT), and can displace zinc due to higher affinity PubMed Central
  • Iron and arsenic have an antagonistic relationship—sufficient iron mitigates arsenic toxicity through competitive binding PubMed Central
  • Calcium deficiency increases intestinal absorption and body retention of lead PubMed Central

Research documents “known interferences such as competition for absorption, enzymatic inhibition, or displacement” between toxic and essential trace elements PubMed Central, creating a vicious cycle: mineral deficiency → increased toxic metal absorption → further mineral displacement → worsening deficiency.

The research pattern is clear: In children with lead exposure, researchers found negative relationships between lead levels and serum calcium and iron, and an inverse association between selenium and iron levels and lead. Children with low iron status had higher levels of cadmium. PubMed Central


Symptoms That May Suggest Heavy Metal Burden:

While symptoms alone cannot confirm heavy metal toxicity, common presentations include:

Neurological:

  • Cognitive dysfunction, memory problems, brain fog
  • Tremors, numbness, tingling
  • Headaches, neuropathy

 

Physical:

  • Chronic fatigue and weakness
  • Joint and muscle pain
  • Digestive issues (nausea, diarrhea, abdominal pain)

 

Immune & Inflammatory:

  • Immune system dysfunction
  • Frequent infections
  • Chronic inflammation

 

Metabolic & Cardiovascular:

  • Hypertension (often associated with zinc deficiency from cadmium/lead displacement)
  • Metabolic dysfunction

Reproductive:

  • Fertility issues
  • Hormonal imbalances

 

Pediatric concerns:

  • Developmental delays
  • Behavioral problems
  • Learning difficulties

How Heavy Metal Burden is Confirmed:

The most reliable way to assess heavy metal burden is through laboratory testing. We use serial testing to track mobilization and excretion over time.

Primary testing method:

Urine Toxic Metals Panel (Doctor’s Data)

  • Tests 20 toxic elements and 18 essential elements
  • Baseline measurement before starting protocol
  • First retest at ~6-8 weeks (mobilization phase—levels expected to rise)
  • Second retest at ~3-4 months (trajectory assessment)

Additional testing options when clinically indicated:

  • Hair Analysis: Reflects longer-term exposure (2-3 months), useful for assessing chronic accumulation
  • Fecal Testing: Measures biliary excretion pathway, useful when gut elimination is suspected to be compromised
  • Blood testing: Generally not used in our program as it only reflects recent/acute exposure, not tissue burden

Key Principle: Lab data drives treatment decisions. We measure at baseline, track mobilization, and measure again to assess trajectory.


When to Seek Heavy Metal Detoxification:

Consider this program if you’re experiencing:

  • Documented exposure to toxic metals (occupational, environmental, dietary)
  • Chronic symptoms consistent with heavy metal burden
  • Known trace mineral deficiencies (iron, zinc, selenium, calcium, copper) coupled with exposure risk
  • Elevated toxic metals on baseline laboratory testing
  • Failed improvement with other interventions despite addressing nutrition, lifestyle, and underlying conditions

The double burden—mineral depletion + metal accumulation—requires a approach that addresses both simultaneously. Consumer supplements and IV chelation do not.

Our treatment program seeks to create conditions where:

  • Natural detoxification pathways function optimally
  • Trace minerals are restored through dissolved ionic minerals
  • Toxic metals are mobilized and excreted through hepatic, renal, and biliary pathways

Are the prescriptions included in the cost?

Quick Answer: This program optimizes cellular water quality—creating the electrochemical environment required for biological detoxification pathways to function. It addresses the double burden of trace mineral deficiency and heavy metal accumulation. It’s not about “supplementing minerals” or “chelating metals.” It’s about fixing the foundational conditions where all cellular processes occur.

Understanding the Real Mechanism:

Most “detox” products are based on a semi-flawed premise: that you can safely pull metals out with binders or chelators.

They miss the fundamental question: What cellular environment allows heavy metals to accumulate in the first place, and what environment allows the body to naturally eliminate them?

The answer: When the water environment inside and around your cells is optimized—stable electrochemical gradients, buffered redox conditions, organized ionic transport—your body’s detoxification pathways work as designed.

This is not about aggressively stripping the body through chelating agents. It’s about creating the right conditions for the body to rid itself of toxins.


How This Program Is Fundamentally Different:

Feature Generic Supplement “Detox” IV Chelation Leading Edge Clinic HMD Program
Mechanism High-dose binders, or “detox” compounds Chelating agents (EDTA, DMPS) force metals out Ionic minerals create ordered water chemistry which aides redox buffering and stabilizes gradients
Foundational premise Add compounds to push out metals Bind and remove metals forcefully Optimize cellular environment so detox pathways function naturally
Addresses cellular enviornment? No No Yes—this is the core mechanism
Addresses trace mineral deficiency? Sometimes (single minerals in high doses) No—worsens it by indiscriminately binding beneficial minerals Yes—dissolved ionic minerals restore the full spectrum
Addresses the double burden? No—ignores that mineral deficiency enables metal accumulation No—makes mineral depletion worse. Sub-optimal at mobilizing metals in tissue Yes—optimizes cellular environment AND provides broad-spectrum trace minerals
Selectivity Variable, often non-selective binders Indiscriminate—binds zinc, magnesium, calcium along with lead and mercury Selective—supports natural pathways that preferentially eliminate toxic metals
Works with cellular electrochemistry? No No Yes
Medical oversight None Physician-administered Licensed clinician supervision
Dosing protocol One-size-fits-all Standardized IV dose Weight-based, individualized
Lab monitoring Optional or absent Variable Baseline + 2 retests (serial tracking)
Mobilization education Rarely addressed Sometimes Central to patient education at Visit 1
Clinical evidence Marketing claims Limited published case data 50-patient IRB study + published case research
Trace mineral breadth Usually single minerals (zinc, selenium) in megadoses None—depletes minerals Broad-spectrum dissolved ionic minerals (many in ppb)—not “supplementation”
Side effect profile Variable, often GI distress Significant (fatigue, mineral depletion, kidney stress) Generally well-tolerated
Convenience At-home Requires in-person IV visits Oral dosing at home, telehealth visits
Cost $50-$150 (product only) $2,000-$5,000+ (10-20+ sessions) $2,500 all-in (includes clinical oversight, labs, and ionic mineral solution)
Addresses root cause No—ignores why metals accumulated No—ignores cellular environment Yes—restores cellular environment

The Role of The Ionic Mineral Solution

This is about the optimizing water—the medium in which all biological processes occur.

Optimized water helps:

1. Stabilize Electrochemical and Proton Gradients

  • Membrane potentials maintained
  • Proton gradients preserved—critical for controlled release of heavy metal cations from binding sites
  • Charge separation across interfaces intact
  • Result: Detoxification pathways can operate in controlled, organized fashion

2. Buffered Redox Conditions

  • Redox reactions (oxidation-reduction) are controlled rather than chaotic
  • Prevents oxidative damage during detoxification
  • Maintains stability of redox-sensitive enzymes
  • Result: Detoxification proceeds without collateral cellular damage

3. Organized Ionic Environments

  • Reduced ionic chaos—controlled, coherent ion movement
  • Better selectivity in ion channels and transporters
  • Stable coordination of metal ions during processing
  • Result: Heavy metals are transported and excreted rather than trapped or re-deposited

4. Stabilized Biological Interfaces

  • Most cellular processes occur at interfaces—membranes, protein surfaces, mineral-cell boundaries
  • Optimized water maintains functional geometry at these critical zones
  • Result: Detoxification enzymes bind substrates correctly, transport proteins move toxins efficiently

5. Increased Protein Folding Stability

  • Detoxification enzymes require proper 3D folding to function
  • Poor water quality causes protein denaturation (unfolding)
  • Optimized water favors folded, functional protein states
  • Result: Liver cytochrome P450 enzymes, glutathione transferases, and renal transport proteins maintain activity

When these conditions are met, the body eliminates heavy metals naturally.


Why IV Chelation Misses the Point:

IV chelation operates on brute force: synthetic molecules bind metals indiscriminately and pull them out.

The fundamental problems:

  1. Doesn’t address the cellular environment that allowed accumulation in the first place
  2. Indiscriminate binding—strips essential minerals along with toxic ones
    • Chelating agents don’t distinguish between lead and zinc, mercury and magnesium—competitive inhibition and displacement affect both essential and toxic minerals PubMed Central
    • Zinc, copper, calcium, magnesium, iron—all bound and removed
  3. Worsens the double burden—makes trace mineral deficiency worse at the exact moment your body needs minerals most
  4. No redox buffering—oxidative stress during forced mobilization
  5. Destabilizes electrochemical gradients—disrupts the very conditions needed for controlled detoxification
  6. Requires aggressive mineral repletion—because it depletes what the body needs

Result: Short-term metal reduction, but the cellular dysfunction and mineral depletion that enabled accumulation remains. Toxins often re-accumulate. Research shows that calcium deficiency increases intestinal absorption and body retention of lead—IV chelation that depletes calcium makes future accumulation more likely. Deanna Minich


Our Approach:

  • Fix the cellular water environment—stable gradients, buffered redox, organized ion transport
  • Restore trace mineral balance through dissolved ionic minerals—addressing the deficiency that enabled accumulation
  • Provide conditions where proton gradients can shift and release bound heavy metal cations
  • Support natural detoxification pathways—hepatic demethylation, renal excretion, biliary elimination
  • Create long-term cellular health—not just temporary metal removal
  • Address the double burden—both toxic metal accumulation AND trace mineral deficiency

This is about restoring foundational biology, not forcing a process.


The Published Case Evidence:

Scott Marsland FNP-C’s case study “From Fatigue to Fertility” documents what happens when cellular water quality is optimized and trace mineral balance is addressed:

Patient presentation:

  • Chronic fatigue, history of renal inflammation
  • 1 year of unsuccessful conception attempts
  • Blood mercury >10× population median at baseline
  • Suspected trace mineral deficiency (common pattern with heavy metal burden)

Treatment protocol:

  • Oral ionic mineral solution (weight-based dosing)
  • Daily therapeutic bathing (transdermal exposure—optimizing water quality systemically)

Measured outcomes:

  • Blood methylmercury: ↓ ~9% (neurotoxic form declining)
  • Urinary inorganic mercury: ↑ +115% (active hepatic demethylation—proof the liver’s natural pathway is working)
  • Blood lead: ↓ 30-35%

What this tells us:

The +115% increase in urinary inorganic mercury is not “minerals pushing metals out” or “chelators binding metals.”

It’s proof that the liver’s demethylation enzymes are functioning—converting fat-soluble methylmercury (hard to excrete) into water-soluble inorganic mercury (easily excreted by kidneys).

This is natural detoxification, enabled by optimized cellular conditions and restored mineral balance.

2026 update (8 months later):

  • Viable pregnancy, second trimester
  • Mercury and lead continuing downward trend
  • Zero new complaints
  • Protocol maintained

Bottom line: This is not mineral supplementation. This is not chelation. This is cellular water optimization and trace mineral restoration—creating the electrochemical environment where your body’s natural detoxification pathways can function as they’re designed to, while addressing the mineral deficiency that enabled accumulation in the first place.

What does the heavy metal detox treatment process look like?

Quick Answer: Three clinician visits over 4 months, three urine toxic metals panels, and a weight-based oral dosing protocol. Some patients may continue with à la carte monitoring beyond the initial program if the heavy metal mobilization and clearance goes beyond the initial 4 month period.

Your Treatment Journey:

Pre-Visit
  • Register for program with our office staff
  • Nursing staff orders Doctor’s Data Urine Toxic Metals & Essential Elements test to your home
  • Upon completion of 24 hour sample gathering and return package submission to lab, patients call office staff to schedule initial appointment
Visit 1 — Initiation (Day 0, 60 minutes)
  • Comprehensive history and screening
  • Informed consent (mechanism, FDA status, expected timeline)
  • Baseline urine toxic metals panel reviewed
  • Weight-based oral dosing protocol established
  • Topical use guidance: bathing ratios, wound care, skin/acne application
  • Critical expectation-setting: Labs will rise before they fall (mobilization arc)
  • Second test is ordered and retesting sample collection date is established

You leave this appointment understanding the mobilization arc before it happens.

Visit 2 — Mobilization Check (~6-8 weeks, 30 minutes)
  • First retest results reviewed
  • Labs expected to be elevated—this is the mechanism working
  • Clinical context provided for the counterintuitive result
  • Dosing adjusted if indicated
  • Validation that the protocol is on track
  • Third test is ordered and retesting sample collection date is established
Visit 3 — Progress Review (~3-4 months, 30 minutes)
  • Second retest results reviewed
  • Trajectory assessment: plateau, early downslope, or continued mobilization
  • Natural continuation conversation:
    • Some patients approaching resolution
    • Others need extended monitoring via à la carte visits
  • If patient is still on a mobilization and excretion arc, discussion on ordering of an additional test (would be an additional cost of $150)
Continued Care — À La Carte Visits ($450/visit)

After Visit 3 and the second retest, some patients continue with ongoing monitoring and titration. Early IRB data suggests some patients require a 6+ month treatment arc. Continued care visits are expected to be a meaningful component of these patient journeys.

These visits do not require re-enrollment in the base program—they are billed per visit as needed.


What to Expect Along the Way:

Weeks 1-6:

  • Beginning oral dosing protocol
  • Topical applications (bathing, wound care, skin support)
  • Metals mobilizing from tissue into circulation
  • First retest scheduled around week 6-8

Weeks 6-8 (Visit 2):

  • First retest results: urinary metals likely elevated
  • Dosing adjustments if needed
  • Continued adherence to protocol

Weeks 8-16:

  • Ongoing dosing and topical use
  • Potential early downslope in some patients
  • Second retest scheduled around week 12-16

Week 12-16 (Visit 3):

  • Second retest results: trajectory assessment
  • Determine need for continued care
  • Expectation of essential beneficial minerals rising
  • À la carte visit planning if extended monitoring indicated

Beyond Month 4:

  • Some patients see sustained downslope and taper protocol
  • Others continue monitoring every 6-8 weeks until resolution
  • Clinical observation from IRB data: full resolution can take 6+ months

Lab Testing:

All patients complete three urine toxic metals panels during the base program:

  1. Baseline (before starting protocol)
  2. First retest (~6-8 weeks)
  3. Second retest (~3-4 months)

Lab provider: Doctor’s Data via Rupa Health

Additional retests may be needed for patients requiring extended monitoring.


Broader Wellness Guidance:

Beyond heavy metal detoxification, the program includes guidance on therapeutic applications of the mineral solution:

  • Therapeutic bathing: Diluted solution added to bath water for systemic transdermal mineral exposure (documented in Fatigue to Fertility case study)
  • Wound care: Topical application to minor wounds, cuts, burns, skin irritation
  • Skin and acne support: Spot application with proper dilution ratios for facial and body skin care

Why this matters:

  • Extends perceived value beyond lab numbers
  • Gives patients something immediately useful during mobilization phase
  • Topical benefits are felt quickly—keeps patients engaged during slower internal detox

Our Treatment Philosophy:

Data-Driven, Not Guesswork

  • Lab results guide every decision
  • Serial monitoring tracks progress objectively
  • No speculation—we measure, mobilize, measure again

Transparent About the Arc

  • Mobilization phase (labs rising) is explained upfront
  • Patients are never left confused about what their labs mean

Individualized Dosing

  • Weight-based protocol developed from IRB study
  • Adjusted based on individual response
  • Not one-size-fits-all

Long-Term Thinking

  • Extended treatment arc acknowledged from day one
  • À la carte continuation pathway built into program design
  • No pressure to resolve in 3 months if body needs more time

Will I see results?

The short answer: Yes. Results are measured objectively through serial lab testing, and 90%+ of patients demonstrate measurable reductions in urinary toxic metal levels over the course of treatment.

The honest answer: The treatment arc is not linear, and full resolution could potentially take 6+ months. Patience and adherence are required.


What “Results” Actually Look Like:

In heavy metal detoxification, results are defined by lab data, not subjective symptom improvement alone.

Expected lab trajectory:

  • Baseline: Metals stored in tissues, urinary excretion low to moderate
  • First retest (6-8 weeks): Urinary levels rise—often dramatically—as metals mobilize from tissues into circulation
  • Second retest (3-4 months): Trajectory assessment—plateau, early downslope, or continued mobilization
  • If necessary, continued monitoring (4+ months): Sustained downslope, reduction in tissue burden

This is not intuitive. Most patients expect lab values to drop immediately. In reality, rising labs at the first retest mean the protocol is working.


Clinical Evidence:

Our program is informed by:

50-patient IRB study:

  • Documented mobilization arc: baseline → peak → downslope
  • Consistent pattern across clinical cohort
  • Timeline variability: some patients show early downslope, others require 6+ months

 

Published case study (“From Fatigue to Fertility”):

  • Blood methylmercury (MeHg): ↓ ~9% (dominant neurotoxic form declining)
  • Urinary inorganic mercury: ↑ +115% (consistent with active hepatic demethylation and renal excretion)
  • Blood lead: ↓ 30-35% (mineral-competitive displacement)
  • 2026 update (8 months later): Viable pregnancy, second trimester, mercury and lead continuing downward trend

What Determines Your Results:

Favorable factors:

  • Adherence to oral dosing treatment guidance
  • Patience through mobilization phase
  • Attendance at all three program visits for treatment adjustments
  • Willingness to continue à la carte monitoring if needed

 

More challenging factors:

  • Ongoing high-level exposure (occupational, dietary, environmental)
  • Non-adherence to protocol
  • Unwillingness to continue monitoring beyond 3-4 months if body needs more time

Symptom Improvement vs. Lab Improvement:

Important distinction:

  • Lab improvement is objective and measurable
  • Symptom improvement is subjective. Sometimes it comes before lab improvement.

Some patients report feeling better immediately during treatment. Others don’t notice symptom changes until months into the downslope. This does not mean the protocol isn’t working. It means tissue burden reduction takes time.

We track labs, not just symptoms. If urinary toxic metal levels are declining, the protocol is achieving its intended outcome.


Timeline Expectations:

Month 1-2:

  • Mobilization phase beginning
  • Labs expected to rise at first retest
  • Many patients report increased energy and cognition; some patients report herxheimer reactions

Month 3-4:

  • Second retest showing trajectory
  • Some patients are well into downslope
  • Other patients are continuing mobilization—both are normal

Month 6+:

  • Sustained downslope expected in most patients
  • Continued à la carte monitoring for those still resolving
  • Gradual tapering of protocol as tissue burden reduces

Full resolution timeline varies. IRB data shows some patients resolve in 4 months, other in 6+ months. This is not failure—it’s individual biology and exposure levels.


What “Success” Looks Like:

Lab-Defined Success:

  • Measurable reduction in urinary toxic metal levels from baseline to final retest
  • Sustained downslope over serial monitoring
  • Return to or below population reference ranges

 

Clinical Success:

  • Adherence to protocol through mobilization phase
  • Completion of all three program visits
  • Continuation with à la carte monitoring if indicated
  • Patient understanding of their own treatment arc

 

Symptom Success (variable):

  • Some patients report energy improvement, cognitive clarity, or other symptom resolution
  • Others notice minimal subjective change despite objective lab improvement

This program is not a quick fix. It is a clinician-supervised, lab-monitored protocol designed to achieve measurable reduction in toxic metal burden over time. It is a gentle protocol, unlike IV chelation which may achieve more rapid results, but doesn’t with negative impacts (ie: beneficial element binding, and not addressing underlying biological issues).

If you’re looking for objective, evidence-based heavy metal reduction with medical oversight, this program delivers.

What is competitive mineral displacement?

Heavy metals occupy binding sites in the body that should be filled by beneficial minerals. When you provide bioavailable ionic minerals in therapeutic ratios, they naturally compete for those binding sites, displacing toxic metals without synthetic chelating agents.

Clinical evidence for this mechanism:

  • Published case study showing 30-35% reduction in blood lead alongside mineral protocol
  • +115% increase in urinary inorganic mercury (consistent with hepatic demethylation and renal excretion)
  • No reported mineral depletion or need for aggressive supplementation

This approach:

  • Works with the body’s physiology, not against it
  • Supports your cellular environment and mineral balance
  • Allows for telehealth delivery (no IV required, no travel required)
  • Is almost always well-tolerated with minimal side effects

Bottom line: If you’re looking for heavy metal detoxification without the risks, costs, and inconvenience of IV chelation, this program offers an evidence-based alternative with measurable outcomes. It does so gently. Our approach to heavy metal detoxifications addresses the underlying cellular environment. Lastly, our approach deals with two sides of the issue – getting rid of heavy metals, and supporting trace mineral repletion.

How is this different from IV Chelation?

Quick Answer: IV chelation uses synthetic chelating agents (like EDTA or DMPS) that bind indiscriminately to both toxic and essential minerals, requiring careful monitoring and often causing significant mineral depletion. Our program uses ionic mineral supplementation and mineral-competitive displacement, which selectively targets toxic metals while supporting cellular hydration and mineral balance.

Why We Don’t Use IV Chelation:

Traditional IV chelation with EDTA or DMPS can be effective for acute heavy metal poisoning, but it comes with significant trade-offs:

  • Indiscriminate binding: Chelating agents don’t distinguish between lead and zinc, mercury and magnesium. You lose good minerals along with the bad.
  • Mineral repletion burden: Patients often need aggressive supplementation to replace depleted essential minerals.
  • Cost and accessibility: IV chelation requires in-person visits, clinical infrastructure, and often 10-20+ sessions at $200-$300 each.
  • Side effect burden: Fatigue, mineral imbalance, and potential kidney stress are common.

Our program offers a fundamentally different approach: support the body’s natural detoxification pathways through mineral-competitive displacement and supporting the cellular environment, rather than forcing metals out indiscriminately.

Additional Heavy Metal Detox Resources

From Fatigue To Fertility - A case study by Scott Marsland FNP-C on the use of ionic minerals for heavy metal mobilization and excretion

Clinical Evidence & Research

Coming soon… our 50-patient IRB study demonstrating the heavy metal mobilization and clearance arc using ionic sulfated trace minerals, versus a control group.

From Fatigue To Fertility - A case study by Scott Marsland FNP-C on the use of ionic minerals for heavy metal mobilization and excretion

Case Study: From Fatigue To Fertility

Read Scott Marsland FNP-C published case study “From Fatigue to Fertility” and the 2026 pregnancy update documenting measurable mercury and lead reduction alongside clinical improvement.

Photo of Nurse Practitioner Briana Bowden, who specializes in Adjunctive Cancer Care, Hormone Evaluation, Thyroid/Adrenal Evaluation, and Gut Health at Leading Edge Clinic

See Our Providers

Check out our clinical team, and learn more about their backgrounds.

 

Opus Health logo

Leading Edge Clinic has partnered with Opus Health to help patients unlock HSA/FSA funds and save on care.

Click this popup to learn more